Shrinking indications for azathioprine in Crohn's disease: A conclusion too premature?

Gastroenterology

Volumn 146, Issue 3, 2014, Pages 866-867

  Rammohan, Haimavati ^a   Pai, C Ganesh ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; MERCAPTOPURINE; PLACEBO; PREDNISONE; THIOPURINE METHYLTRANSFERASE;

CROHN DISEASE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; LETTER; PRIORITY JOURNAL; REMISSION; TREATMENT FAILURE; TREATMENT INDICATION;

AZATHIOPRINE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 84894306998     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.10.071     Document Type: Letter

References (8)

1. J. Cosnes et al. Gastroenterology 145 2013 758 765
2. J. Panés et al. Gastroenterology 145 2013 766 774
3. G.R. Lichtenstein et al. Gastroenterology 130 2006 935 939
4. C. Mowat et al. Gut 60 2011 571 607
5. J.R. Boulton-Jones et al. Aliment Pharmacol Ther 14 2000 1561 1565
6. C.H. Seow et al. Cochrane Database Syst Rev 16 2009 CD000296
7. L. Peyrin-Biroulet et al. Gut 60 2011 930 936
8. A.B.R. Thomson et al. World J Gastroenterol 18 2012 4823 4854